Idenix Pharma initiated with "outperform"
10/21/09 - Wedbush Morgan Securities
NEW YORK, October 21 (newratings.com) - Analysts at Wedbush Morgan initiate coverage of Idenix Pharma (IDEX) with an "outperform" rating. The target price is set to $5.
Share Recommend this article to a friend add IDIX to my stocks and get e-mail alerts on Idenix Pharmaceuticals
|Latest actions||previous | next|
|09/08/10||Idenix Pharma downgraded to "market perform"||JMP Securities|
|07/14/10||Idenix Pharmaceuticals initiated with "buy"||Stifel Nicolaus|
|10/30/09||Idenix Pharma downgraded to "above average"||Caris & Company|